Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-17933
Zeilhofer, H U; Witschi, R; Hösl, K (2009). Subtype-selective GABA(A) receptor mimetics-novel antihyperalgesic agents? Journal of Molecular Medicine, 87(5):465-469.
- Registered users only
View at publisher
Agonists at the benzodiazepine-binding site of ionotropic gamma-aminobutyric acid (GABA(A)) receptors are in clinical use as hypnotics, anxiolytics, and anticonvulsants since the early 1960. Analgesic effects of classical benzodiazepines have occasionally been reported in certain subgroups of patients suffering from chronic pain or after spinal delivery through intrathecal catheters. However, these drugs are generally not considered as analgesics but should in fact be avoided in patients with chronic pain. Recent evidence from genetically modified mice now indicates that agents targeting only a subset of benzodiazepine (GABA(A)) receptors should provide pronounced antihyperalgesic activity against inflammatory and neuropathic pain. Several such compounds have been developed recently, which exhibit significant antihyperalgesia in mice and rats and appear to be devoid of the typical side-effects of classical benzodiazepines.
2 downloads since deposited on 13 Jul 2009
0 downloads since 12 months
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > Institute of Pharmacology and Toxicology|
|Dewey Decimal Classification:||570 Life sciences; biology
610 Medicine & health
|Deposited On:||13 Jul 2009 06:51|
|Last Modified:||05 Apr 2016 13:11|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page